The study found that nonuse of antidepressants was associated with 3.5x higher risk of neurodegeneration, but the protective mechanism is unexplained. Understanding this could reveal novel neuroprotective pathways and inform therapeutic strategies. Gap type: unexplained_observation Source paper: Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. (2015, Neurology, PMID:25681454)
Landscape Summary: Why does antidepressant use protect against synucleinopathy conversion in RBD patients? is a 0.79 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Why does antidepressant use protect against synucleinopathy conversion in RBD patients? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: